Metformin’s Potential Role in Posterior Capsule Opacification - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Metformin’s Potential Role in Posterior Capsule Opacification

Common diabetes therapy reaches intraocular lens tissue and may help limit PCO, says newly published data

  • March 30, 2026

  • 3 min

Share

  • 1

    Metformin may reduce the incidence of posterior capsule opacification (PCO), a common complication after cataract surgery.

  • 2

    A study found that metformin accumulates in the human lens capsule, correlating with serum concentrations in patients.

  • 3

    In vitro assays demonstrated that metformin significantly attenuates lens epithelial cell proliferation compared to controls.

  • 4

    The findings suggest that metformin use may modify PCO risk, challenging previous epidemiological data on diabetes and PCO.

  • 5

    The authors advocate for larger studies to explore metformin as a potential adjunct treatment for preventing PCO.

Original Source(s)

Metformin’s Potential Role in Posterior Capsule Opacification

  • March 30, 2026

Related Content

Smartphone Imaging System Supports Remote Cataract Screening

A low-cost smartphone imaging system could help expand cataract screening in rural and underserved communities.

  • September 11, 2026

  • 2 min
How to Stay at the Forefront of Ophthalmology

Forty-four years in, Heaton Eye is still learning, but its foundation hasn't changed. "We believe in the technologies we offer, we prepare our team for success, and we let the outcomes do the rest."

Coastal Eye Associates Welcomes Dr. Sanchay Gupta

Comprehensive ophthalmologist specializing in advanced cataract surgery joins Houston-area practice

  • September 7, 2026

  • 2 min